Treatment of 40 patients with primary tracheal carcinoma.
- Author:
Kai-liang WU
1
;
Guo-liang JIANG
;
Xiao-long FU
;
Yun-zhong ZHOU
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Aged; Cobalt Radioisotopes; Female; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Particle Accelerators; Radiotherapy, Adjuvant; Survival Rate; Tracheal Neoplasms; mortality; radiotherapy; surgery; Tracheotomy; methods
- From: Chinese Journal of Oncology 2004;26(4):244-246
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo study the efficacy of treatment in 40 patients with primary tracheal carcinoma.
METHODSFrom 1970 to 2001, 40 patients with primary tracheal carcinoma treated in our hospital were retrospectively reviewed. Twenty-eight were male and 12 were female with median age of 47 years. The median interval from onset of symptoms to diagnosis was 10 months (1 - 60 months). Fifteen patients had adenoid cystic carcinoma, 14 squamous cell carcinoma, 8 adenocarcinoma, 2 small-cell carcinoma and 1 mucoepidermoid carcinoma. Thirty-two patients received operation plus adjuvant radiotherapy, 6 received radiotherapy alone and 2 received operation alone.
RESULTSThe median survival time for all patients was 40 months. The 1-, 5-, and 10-year survival rate was 86%, 59% and 29%, respectively. The 1-, 5-, and 10-year local control rate was 84%, 60% and 50%, respectively. Distant metastasis rate in 1, 5, and 10 years was 17%, 51% and 84%, respectively.
CONCLUSIONSurgical resection plus adjuvant radiotherapy is a reasonable mode of treatment. Despite late local recurrence after initial treatment, its intrinsic feature, excellent long-term palliation can be achieved after treatment.